HOME >> BIOLOGY >> NEWS
Victoria Hale of Institute for OneWorld Health Named Fellow by International Women's Forum

The Institute for OneWorld Health, the first nonprofit pharmaceutical company in the United States, today announced that CEO Victoria Hale, Ph.D., has been named a Leadership Foundation Fellow for 2003-2004. Hale is one of 14 women selected from a field of more than 50 finalists from all over the world. She is founder and CEO of OneWorld Health, whose experienced team of pharmaceutical scientists uncovers promising drug candidates and advances them through clinical trials and regulatory approval to treat the poorest people in the developing world.

This honor is the third international award in three weeks that recognizes Hale's leadership and vision in establishing OneWorld Health. On Sept. 3 she was named one of five global laureates in health by the Tech Museum of Innovation (San Jose, Calif.). One week prior to that, she was selected as one of 10 outstanding global entrepreneurs by the Schwab Foundation for Social Entrepreneurship in Geneva, Switzerland (http://www.oneworldhealth.org/news/news.html).

The Leadership Foundation is the educational and charitable arm of the International Women's Forum, a global association of about 3,800 top women leaders from 20 countries. The Leadership Foundation Fellows Program is the only leadership training of its kind in the world, designed for women of cultural, professional and geographic diversity. Aimed at high potential women who have the ability to excel at the highest levels of their organizations, the Fellows Program sustains, grooms and promotes up-and-coming women leaders.

Hale's pharmaceutical career spans 15 years, including regulatory and industry experience at the U.S. Food and Drug Administration and biotech pioneer Genentech, Inc. At the FDA, Hale and a team of colleagues led a successful two-year campaign to ensure women and minorities were included in clinical trials, ending an exclusionary practice that persisted in
'"/>

Contact: Joanne Hasegawa
jhasegawa@oneworldhealth.org
415-421-4700 x322
Institute for OneWorld Health
15-Sep-2003


Page: 1 2

Related biology news :

1. Schwab foundation names Victoria Hale a social entrepreneur for 2004
2. NIH awards $18.2m to The Burnham Institute to develop Center on Proteolytic Pathways
3. Schepens Eye Research Institute receives Roadmap grant to develop center for curing eye diseases
4. The future of HIV therapeutics is brightening, according to Gladstone Institutes Director
5. Institute for OneWorld Health nominated for the 2004 World Technology Awards
6. UNC researchers awarded $8.65 million from National Institute on Aging
7. Institute for OneWorld Health receives Gates Foundation grant
8. Lupus Research Institute awards $3 million in novel research grants to further new science in lupus
9. Virginia Bioinformatics Institute researcher advances fight against sudden oak death disease
10. Institute for OneWorld Health CEO to speak at BIO on leveraging opportunities for global health
11. Institute for OneWorld Health CEO advocates focus first on developing world markets

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2019)... ... ... In the wake of the success of IBBL’s international ... was launched in July 2018, in an agreement between IBBL, the International Society ... Association (BBCMBA). The one-year pilot programme offered two testing schemes: ‘DNA quantification and ...
(Date:3/29/2019)... ... March 29, 2019 , ... GenCure has selected G-CON Manufacturing, ... facility. The new facility, which will anchor the VelocityTX innovation center in San ... manufacturing capabilities to support clinical cell therapy trials. GenCure is a subsidiary of ...
(Date:3/26/2019)... ... March 26, 2019 , ... ... introduce the four recipients of the Society's 2019 Outstanding Achievement Award, Outstanding New ... will be presented at the ASGCT 22nd Annual Meeting . , Outstanding ...
Breaking Biology News(10 mins):
(Date:4/10/2019)... ... April 10, 2019 , ... ... locked into multiple agreements to help companies advance their innovations to clinical ... ranging from synthetic biology companies that are gene editing therapeutic cells for ...
(Date:4/9/2019)... ... , ... Sonny Bar Lisa, or Sonny for short, is a quarter horse ... a series of diagnostics, an MRI was performed which revealed Sonny had torn his ... found that VetStem Regenerative Cell Therapy may be a treatment option for ...
(Date:4/8/2019)... SAN FRANCISCO (PRWEB) , ... April 08, 2019 , ... ... to accredited investors a $15 million preferred equity investment in the privately held pharmaceutical ... dysfunction. Its leading drug, Lorexys, is targeted at female hypoactive sexual dysfunction disorder and ...
(Date:4/4/2019)... ... April 03, 2019 , ... LeadingBiotech, an exclusive ... dialogue, today announces its Boston CEO conference to be held May 28-29, 2019 ... and opportunities with high-level panels and discussions from past, present and future change-makers. ...
Breaking Biology Technology:
Cached News: